Search results

PurposeThere is growing awareness that global public health problems are so complex, and require such major resources, that neither states nor other stakeholders can tackle them and achieve the millennium development goals (MDGs) on their own. This paper aims to examine the relevance of the MDGs to the pharmaceutical sector and summarizes the industry's contributions to helping achieve the MDGs in the context of its business goals.Design/methodology/approachThe paper reviews the MDGs for which industry has made significant contributions, particularly goal 4: reduce child mortality; goal 5: improve maternal health; goal 6: combat HIV/AIDS, malaria and other diseases; and goal 8: develop a global partnership for development. The paper focuses on two public‐private partnerships (PPPs) in particular – the Merck MECTIZAN® Donation Program, for the elimination of river blindness as a public health problem, and the African Comprehensive HIV/AIDS Partnerships to address the HIV/AIDS epidemic in Botswana – and outlines some lessons learned. The paper also offers some considerations for PPPs to contribute further to public health and the MDGS in the future.FindingsThe pharmaceutical industry has made some major contributions to addressing public health challenges. Along the way, companies such as Merck & Co., Inc. (Whitehouse Station, New Jersey; Merck operates in most countries outside the USA as Merck Sharp & Dohme) have learned useful lessons that can be shared to inform the approach and practices of other PPPs in global health.Originality/valueRelatively few overviews document the industry's contributions to public health, especially in relation to the MDGs. This paper provides a first step to fill that gap at a time when interest in PPPs is increasing.

Intro -- Contents -- Foreword -- Preface -- Introduction. The Road to Universal Health Coverage: Progress, Prospects, and the Private Sector -- 1. Conceptualizing the Health Economy -- 2. The Relationship between Health Employment and Economic Growth -- 3. Engagement of the Private Sector in Advancing Universal Health Coverage: Understanding and Navigating Major Factors for Success -- 4. Innovative Initiatives from the Private Sector: What Have the Experiences Been? What Opportunities Lie Ahead, and How Can They Be Harnessed More Effectively? -- 5. Healthy Women, Healthy Economies: Essential Facets of Universal Health Coverage -- 6. Reframing the Pharmaceutical Sector Contribution to Access to Medicines and Universal Health Coverage: A Business Ethics Perspective -- 7. The Private Sector Joins the Trek on India's Meandering Path to Universal Health Coverage -- 8. A Reality Check: Sierra Leone, the Private Sector, Sustainable Development Goal 3, and Universal Health Coverage -- 9. How Can the Private Sector Help Countries to Achieve Quality, Sustainable Universal Health Coverage? Pfizer's Fight against Chronic Diseases -- 10. Novartis Social Business: A Novel Approach to Expanding Healthcare in Developing Countries -- Conclusion. The Outlook for Universal Health Coverage and the New Health Economy -- List of Contributors -- Index -- A -- B -- C -- D -- E -- F -- G -- H -- I -- J -- K -- L -- M -- N -- O -- P -- R -- S -- T -- U -- V -- W -- Y -- Z

Introduction : the road to universal health coverage : progress, prospects and the private sector / Jeffrey L. Sturchio and Louis Galambos -- Conceptualizing the health economy / Ilona Kickbusch and Christian Franz -- The relationship between health employment and economic growth / Pascal Zurn, Jim Campbell, Jeremy Lauer, Ibadat Dhilon, Tana Wuliji, and Jean-Louis Arcand -- Engagement of the private sector in advancing UHC : understanding and navigating : major factors for success / Nathan J. Blanchet, Adeel Ishtiaq, and Cicely Thomas -- Innovative initiatives from the private sector : what have been the experiences? what opportunities lie ahead and how can they be harnessed more effectively? / Donika Dimovska and John Campbell, Jr -- Healthy women, healthy economies : essential facets of universal health coverage / Felicia Marie Knaul, Belen Garijo, Christine Bugos, Hector Arreola-Ornelas, and Yasmine Rouai -- Reframing the pharmaceutical sector contribution to access to medicines and universal health coverage : a business ethics perspective / Michael Furst -- Private sector joins the trek on India's meandering path to universal health coverage / K. Srinath Reddy -- A reality check : Sierra Leone, the private sector, sustainable development goal 3 and universal health coverage / Sowmya Kadandale and Robert Marten -- How can the private sector help countries to achieve quality, sustainable UHC : Pfizer's flight against chronic diseases / Justin McCarthy -- Novartis social business : a novel approach to expanding health care in developing countries / Harold Nusser -- Conclusion: prospects / Christian Franz, Louis Galambos, Ilona Kickbusch and Jeffrey L. Sturchio